Search Results - "Laurila, J M M"

Involvement of the first transmembrane segment of human α(2) -adrenoceptors in the subtype-selective binding of chlorpromazine, spiperone and spiroxatrine by Laurila, J M M, Wissel, G, Xhaard, H, Ruuskanen, J O, Johnson, M S, Scheinin, M

“…Some large antagonist ligands (ARC239, chlorpromazine, prazosin, spiperone, spiroxatrine) bind to the human α(2A) -adrenoceptor with 10- to 100-fold lower…”
Get full text

The second extracellular loop of α2A‐adrenoceptors contributes to the binding of yohimbine analogues by Laurila, J M M, Xhaard, H, Ruuskanen, J O, Rantanen, M J M, Karlsson, H K, Johnson, M S, Scheinin, M

“…Background and purpose: Rodent α2A‐adrenoceptors bind the classical α2‐antagonists yohimbine and rauwolscine with lower affinity than the human…”
Get full text

The second extracellular loop of α 2A ‐adrenoceptors contributes to the binding of yohimbine analogues by Laurila, J M M, Xhaard, H, Ruuskanen, J O, Rantanen, M J M, Karlsson, H K, Johnson, M S, Scheinin, M

“…Background and purpose: Rodent α 2A ‐adrenoceptors bind the classical α 2 ‐antagonists yohimbine and rauwolscine with lower affinity than the human α 2A…”
Get full text

The second extracellular loop of alpha2A-adrenoceptors contributes to the binding of yohimbine analogues by Laurila, J M M, Xhaard, H, Ruuskanen, J O, Rantanen, M J M, Karlsson, H K, Johnson, M S, Scheinin, M

“…Rodent alpha(2A)-adrenoceptors bind the classical alpha(2)-antagonists yohimbine and rauwolscine with lower affinity than the human alpha(2A)-adrenoceptor. A…”
Get full text

The second extracellular loop of [alpha]2A-adrenoceptors contributes to the binding of yohimbine analogues by Laurila, J M M, Xhaard, H, Ruuskanen, J O, Rantanen, M J M, Karlsson, H K, Johnson, M S, Scheinin, M

“…BACKGROUND AND PURPOSE: Rodent alpha(2A)-adrenoceptors bind the classical alpha(2)-antagonists yohimbine and rauwolscine with lower affinity than the human…”
Get full text

Risk factors for prolonged intensive care unit stay and hospital mortality in acute drug-poisoned patients: An evaluation of the physiologic and laboratory parameters on admission by Liisanantti, Janne Henrik, MD, Ohtonen, Pasi, MSci, Kiviniemi, Outi, MD, Laurila, Jouko J., MD, PhD, Ala-Kokko, Tero I., MD, PhD

“…Abstract Background The share of patients receiving intensive care treatment because of acute drug poisoning is 2% to 14% of all patients receiving intensive…”
Get full text